Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years

If you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)

Charles McWherter net worth and biography

Charles McWherter Biography and Net Worth

Insider of CymaBay Therapeutics

Dr. McWherter has served as our Chief Scientific Officer and President of Research and Development since November 2022. Previously he served as our Chief Scientific Officer since 2013. From 2007 to 2013 he served as our Senior Vice President, Research and Preclinical Development and from 2003 to 2007, he served as Vice President and head of the cardiovascular therapeutic area of Pfizer Inc. From 2001 to 2003, Dr. McWherter served as Vice President of Drug Discovery at Sugen, Inc., a subsidiary of Pharmacia acquired by Pfizer Inc. in 2003. Dr. McWherter was a Visiting Scientist at the Weizmann Institute of Science in Israel and obtained his Ph.D. in Biophysical Chemistry from Cornell University.

What is Charles McWherter's net worth?: The estimated net worth of Charles McWherter is at least $487,200.00 as of January 19th, 2024. Dr. McWherter owns 15,000 shares of CymaBay Therapeutics stock worth more than $487,200 as of April 26th. This net worth evaluation does not reflect any other investments that Dr. McWherter may own. Additionally, Dr. McWherter receives an annual salary of $700,650.00 as Insider at CymaBay Therapeutics. Learn More about Charles McWherter's net worth.
How old is Charles McWherter?: Dr. McWherter is currently 69 years old. There are 7 older executives and no younger executives at CymaBay Therapeutics. Learn More on Charles McWherter's age.
What is Charles McWherter's salary?: As the Insider of CymaBay Therapeutics, Inc., Dr. McWherter earns $700,650.00 per year. The highest earning executive at CymaBay Therapeutics is Mr. Sujal A. Shah, President, CEO & Director, who commands a salary of $1,040,000.00 per year. Learn More on Charles McWherter's salary.
How do I contact Charles McWherter?: The corporate mailing address for Dr. McWherter and other CymaBay Therapeutics executives is 7575 GATEWAY BOULEVARD SUITE 110, NEWARK CA, 94560. CymaBay Therapeutics can also be reached via phone at (510) 293-8800 and via email at [email protected]. Learn More on Charles McWherter's contact information.
Has Charles McWherter been buying or selling shares of CymaBay Therapeutics?: Charles McWherter has not been actively trading shares of CymaBay Therapeutics in the last ninety days. Most recently, Charles Mcwherter sold 18,403 shares of the business's stock in a transaction on Friday, January 19th. The shares were sold at an average price of $23.67, for a transaction totalling $435,599.01. Following the completion of the sale, the insider now directly owns 15,000 shares of the company's stock, valued at $355,050. Learn More on Charles McWherter's trading history.
Who are CymaBay Therapeutics' active insiders?: CymaBay Therapeutics' insider roster includes Janet Dorling (Director), Dennis Kim (Insider), Charles McWherter (Insider), Daniel Menold (VP), Paul Quinlan (General Counsel), Sujal Shah (CEO), and Kurt von Emster (Director). Learn More on CymaBay Therapeutics' active insiders.
Are insiders buying or selling shares of CymaBay Therapeutics?: In the last year, insiders at the biopharmaceutical company sold shares 27 times. They sold a total of 480,648 shares worth more than $7,806,823.97. The most recent insider tranaction occured on February, 12th when Director Janet Dorling sold 6,000 shares worth more than $191,820.00. Insiders at CymaBay Therapeutics own 7.0% of the company. Learn More about insider trades at CymaBay Therapeutics.
Information on this page was last updated on 2/12/2024.

Charles McWherter Insider Trading History at CymaBay Therapeutics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/19/2024	Sell	18,403	$23.67	$435,599.01	15,000
12/18/2023	Sell	11,332	$21.48	$243,411.36	15,000
11/17/2023	Sell	11,342	$18.28	$207,331.76	15,000
10/18/2023	Sell	21,743	$14.07	$305,924.01	15,000
9/18/2023	Sell	21,746	$16.22	$352,720.12	15,000
8/18/2023	Sell	21,746	$11.47	$249,426.62	15,000
7/18/2023	Sell	21,749	$11.43	$248,591.07	15,000
6/20/2023	Sell	21,749	$8.16	$177,471.84	15,000
5/18/2023	Sell	21,749	$9.08	$197,480.92	15,000
11/2/2017	Buy	5,000	$8.67	$43,350.00	10,300
7/20/2017	Buy	5,000	$7.43	$37,150.00	5,100
4/15/2016	Buy	3,000	$1.68	$5,040.00	5,000
5/15/2015	Buy	2,000	$3.16	$6,320.00

Charles McWherter Buying and Selling Activity at CymaBay Therapeutics

CymaBay Therapeutics Company Overview

CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta for the treatments of primary biliary cholangitis (PBC). The company also develops MBX-2982, a G protein-coupled receptor 119 (GPR119) agonist, in subjects with type 1 diabetes. It has a license agreement with ABW Cyclops SPV LP to support development of seladelpar for the treatment of PBC. The company was formerly known as Metabolex, Inc. CymaBay Therapeutics, Inc. was incorporated in 1988 and is headquartered in Fremont, California.

Today's Range

Now: $32.48

$32.48

50 Day Range

MA: $32.40

$32.17

$32.48

2 Week Range

Now: $32.48

$7.26

$32.50

Volume

73 shs

Average Volume

4,113,430 shs

Market Capitalization

$3.73 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.32

Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share

From Colonial Metals | Ad

The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty.

See why the elites are pouring billions into gold.

Charles McWherter Biography and Net Worth

What is Charles McWherter's net worth?

How old is Charles McWherter?

What is Charles McWherter's salary?

How do I contact Charles McWherter?

Has Charles McWherter been buying or selling shares of CymaBay Therapeutics?

Who are CymaBay Therapeutics' active insiders?

Are insiders buying or selling shares of CymaBay Therapeutics?